Clinical application of biomarkers in prostate cancer in men with metabolic syndrome project: Clinical evaluation of prognostic and metabolic benefits of Metformin in prostate cancer
| Data(s) |
2015
|
|---|---|
| Identificador | |
| Publicador |
Wiley-Blackwell Publishing Ltd. |
| Relação |
DOI:10.1111/bju.13072 Rhee, Handoo, Vela, Ian, Gunter, Jennifer, Jovanovic, Lidija, Hollier, Brett, Williams, Elizabeth, Wood, Simon, Ho, Ken, & Nelson, Colleen (2015) Clinical application of biomarkers in prostate cancer in men with metabolic syndrome project: Clinical evaluation of prognostic and metabolic benefits of Metformin in prostate cancer. In Urological Society of Australia and New Zealand 68th Annual Scientific Meeting, 11–14 April 2015, Adelaide, Australia. |
| Direitos |
Copyright 2015 The Authors |
| Fonte |
School of Biomedical Sciences; Faculty of Health; Institute of Health and Biomedical Innovation |
| Palavras-Chave | #111201 Cancer Cell Biology #111204 Cancer Therapy (excl. Chemotherapy and Radiation Therapy) #111207 Molecular Targets #prostate cancer #clinical application of biomarkers #biomarkers #metabolic syndrome #Metformin |
| Tipo |
Conference Item |
